Column Group

Latest statistics and disclosures from Column Group's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ORIC, TNYA, Surrozen, RAPT, SGMT, and represent 100.00% of Column Group's stock portfolio.
  • Column Group has $70M in assets under management (AUM), dropping by -2.39%.
  • Central Index Key (CIK): 0001833486

Tip: Access up to 7 years of quarterly data

Positions held by Column Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Column Group

Column Group holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Oric Pharmaceuticals (ORIC) 52.2 $36M 3.5M 10.25
 View chart
Tenaya Therapeutics (TNYA) 26.1 $18M 9.4M 1.93
 View chart
Surrozen 13.9 $9.7M 810k 11.98
 View chart
Rapt Therapeutics (RAPT) 7.7 $5.4M 2.7M 2.01
 View chart
Sagimet Biosciences Inc-a (SGMT) 0.1 $48k 17k 2.77
 View chart
Revolution Medicines (RVMD) 0.0 $2.1k 46.00 45.35
 View chart

Past Filings by Column Group

SEC 13F filings are viewable for Column Group going back to 2020